IONS Insider Trading

Ionis Pharmaceuticals, Inc. (IONS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $4.84B, listed on NASDAQ, employing roughly 1,480 people, carrying a beta of 0.40 to the broader market. Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. Led by Brett Monia, public since 1991-05-17.

In the last 12 months, Ionis Pharmaceuticals, Inc. insiders made 3 buy transactions and 101 sale transactions.

DateNameTypeSharesPriceValue
Nov 13, 2026Hayden Michael RP-Purchase5,000$29.64$148.2K
Oct 19, 2026Devers Shannon L.M-Exempt2,820$0.00$0
Oct 19, 2026Devers Shannon L.M-Exempt2,820$0.00$0
Oct 19, 2026Devers Shannon L.S-Sale1,357$43.54$59.1K
Oct 19, 2026Swayze EricM-Exempt125$0.00$0
Oct 19, 2026Swayze EricM-Exempt125$0.00$0
Oct 19, 2026Swayze EricS-Sale53$43.54$2.3K
Sep 2, 2026BENNETT C FRANKJ-Other110$51.31$5.6K
Sep 2, 2026O'NEIL PATRICK R.J-Other63$51.31$3.2K
Sep 2, 2026Monia Brett PJ-Other98$51.31$5.0K

IONS Insider Activity by Quarter

Reported Form 4 and Form 5 lines under IONS's own SEC company ID, by transaction date, back to Q4 2024. Purchases and sales are code P / S (open market or private) in the company's shares; other lines are purchases and sales of other securities (options, warrants, preferred), awards, exercises, tax withholding, gifts and other acquisitions and dispositions. Later filings and amendments can change the current quarter. Earlier quarters are not shown: the filings read reach back to Jul 11, 2023, and a quarter counts only when every filing for it was read.

QuarterPurchasesBoughtSalesSoldOther Lines
Q4 2026 (so far)1$148.2K2$61.4K4
Q3 20262$1.1M6$3.5M30
Q2 20260N/A26$26.5M54
Q1 20260N/A62$76.0M152
Q4 20250N/A33$27.3M56
Q3 20250N/A40$41.3M98
Q2 20251$477.9K3$216.4K6
Q1 20250N/A23$5.2M76
Q4 20242$181.1K4$811.0K3

IONS Institutional Ownership (13F)

As of Jun 30, 2026 (Q2 2026), 513 institutions reported holding 179,752,611 IONS shares, valued at $14.27B as reported, 106.6% of its market cap (market cap of Jun 26, 2026). That is +17 institutions from the quarter before. Among managers whose reports for both quarters are comparable, 54 opened a position, 41 closed one, 201 added and 160 trimmed.

Top Holders, Q2 2026

ManagerSharesValueChange
FMR LLC24,631,956$1.95B+75,319
Capital World Investors21,669,226$1.72B+482,857
BlackRock, Inc.10,704,660$848.8M+262,184
VANGUARD PORTFOLIO MANAGEMENT LLC7,859,529$623.2M+50,627
WELLINGTON MANAGEMENT GROUP LLP7,651,415$606.7M+1,259,599
VANGUARD CAPITAL MANAGEMENT LLC7,211,497$571.8M+93,167
TWO SIGMA INVESTMENTS, LP6,252,342$495.7M+394,713
ROYAL BANK OF CANADA6,182,479$490.2M+2,380,664
STATE STREET CORP4,334,848$343.7M+339,284
T. Rowe Price Investment Management, Inc.3,959,372$313.9M-2,199,655

By Quarter

QuarterInstitutionsSharesValue
Q2 2026513179,752,611$14.27B
Q1 2026496172,627,404$12.97B
Q4 2025493176,289,137$13.94B
Q3 2025434168,717,465$11.04B
Q2 2025361169,650,650$6.70B
Q1 2025339165,924,156$5.01B
Q4 2024351160,472,575$5.61B
Q3 2024349156,089,860$6.25B
Q2 2024354145,666,686$6.94B

From the SEC's Form 13F data sets: investment managers with $100 million or more in Section 13(f) securities report their holdings each quarter, up to 45 days after it ends; a restated filing replaces the original, and values are as the managers reported them (a position whose price runs about 1,000 times below other managers', from a manager whose positions mostly do, is read as reported in thousands of dollars). The same shares can be reported by more than one manager, so totals can count some twice.

ETFs Holding IONS

FundWeight of IONSShares (as reported)Value (as reported)Source updated
XBI State Street SPDR S&P Biotech ETF0.73%2,785,487$78.9MNov 12, 2026
CGGR Capital Group Growth ETF0.16%1,470,232$41.7MNov 13, 2026
IBB iShares Biotechnology ETF0.31%1,254,219$35.5MNov 12, 2026
ARKG ARK Genomic Revolution ETF1.28%942,368$26.7MNov 12, 2026
IWP iShares Russell Mid-Cap Growth ETF0.13%880,148$24.9MNov 12, 2026
SCHA Schwab U.S. Small-Cap ETF0.11%888,374$24.3MNov 13, 2026
IWR iShares Russell Mid-Cap ETF0.03%705,590$20.0MNov 12, 2026
IWF iShares Russell 1000 Growth ETF0.01%584,159$16.5MNov 12, 2026
SCHM Schwab U.S. Mid-Cap ETF0.09%507,307$13.9MNov 13, 2026
CGMM Capital Group U.S. Small and Mid Cap ETF0.28%364,900$10.3MNov 13, 2026
ITOT iShares Core S&P Total U.S. Stock Market ETF0.01%220,150$6.2MNov 12, 2026
NUSC Nuveen ESG Small-Cap ETF0.33%156,426$4.3MNov 13, 2026
SMLF iShares U.S. Small-Cap Equity Factor ETF0.09%139,975$4.0MNov 12, 2026
IYH iShares U.S. Healthcare ETF0.07%113,199$3.2MNov 12, 2026
IWB iShares Russell 1000 ETF0.01%112,609$3.2MNov 12, 2026

From each fund's latest holdings file on record that shows IONS's listed security itself. A file counts when its line count is consistent with the fund's reported holdings count (at most twice it plus 10, or at most 1,000 lines for a reported count of exactly 10, which the data source gives many funds as a cap), read with that file or inherited from the fund's last classified file (within 20% of its line count, read within 60 days). Funds whose line for the company could not be confirmed as IONS's listed security, or that hold it through underlying funds (look-through), are not listed. Only long positions count: a fund is left out when any of its lines for IONS reports a negative weight, share count or value, or none of them above zero (a short position, or figures that disagree). Shares, value and weight are as reported in each fund's file, dated by the data source's last update of that file (not the date of the positions); the weight is IONS's share of that fund.

IONS Congress Trades

Members of Congress and their households disclosed 2 transactions in IONS on file (0 purchases, 2 sales) by 2 members, the latest trade on Mar 6, 2023.

MemberChamberTypeAmountTradedDisclosed
Daniel S. Goldman (D-NY-10)HouseSale (Full)$1,001 - $15,000Mar 6, 2023Apr 17, 2023
Sheldon Whitehouse (D-RI)SenateSale (Full)$1,001 - $15,000Jan 20, 2016Feb 23, 2016

From the periodic transaction reports members of the Senate and the House file under the STOCK Act, within 45 days of a trade (some file later); amounts are the ranges the reports give (a few give an exact amount), and a transaction a later report lists again is counted once. On file: House reports disclosed from Apr 10, 2023 through Nov 13, 2026; Senate reports disclosed from Jan 30, 2014 through Nov 4, 2026. The party is the member's on the trade date. A trade is listed under the company that traded under its ticker on the trade date (dated from Feb 1, 2021, unless the filing describes another company of ours; before that, only when the filing's description of the security is the company's name).

How to Read IONS Insider Activity

Net insider sentiment skews to the sell side over the trailing twelve months: 101 sales versus 3 buys. Insider sales carry less informational weight than buys because they are often driven by liquidity, tax planning, or pre-scheduled Rule 10b5-1 trading plans rather than negative information. The transaction type alone does not say whether a sale was made on the open market or privately, or under a 10b5-1 plan; the filing's plan checkbox and footnotes do. The transaction table above includes the filer's reporting name, transaction type, share count, per-share price, and total dollar value where computable. For options traders, insider activity is one input to event-driven sizing alongside earnings calendar, analyst-rating cluster moves, and the implied-vol surface. Form 4 filings (the dominant Section 16 reporting form) must be submitted within two business days of the transaction; clusters of buys across multiple insiders within a short window are the strongest informational pattern. SEC EDGAR carries the underlying source filings for verification and additional historical depth.

Learn how insider trading is reported and how to read the data →

Frequently asked IONS insider trading questions

How active are IONS insiders right now?
Over the trailing twelve months, Ionis Pharmaceuticals, Inc. (IONS) insiders made 3 buy transactions and 101 sale transactions. Net insider sentiment over the trailing twelve months tilts to the sell side (101 sales vs 3 buys). The transaction list above shows the most recent filings; each entry includes the insider's name, transaction type, share count, and per-share price.
What counts as an insider transaction?
Section 16 of the Securities Exchange Act requires officers, directors, and 10% beneficial-owner shareholders to disclose changes in their holdings via Form 3 (initial statement), Form 4 (subsequent transactions, filed within two business days), and Form 5 (annual catch-up). Insider transactions cover open-market purchases and sales, exercise of stock options, gifts, and grants. The "transaction type" field on each row distinguishes these subcategories.
Are IONS insider buys a bullish signal?
Insider purchases (Type P, made on the open market or privately; the code covers both) carry more informational weight than insider sales: an insider must commit personal capital, and the SEC scrutinizes purchases under Rule 10b5-1 for material non-public information. Sales, by contrast, are often driven by liquidity, tax planning, or pre-scheduled 10b5-1 trading plans rather than negative information. Cluster buying (multiple insiders buying within a short window) is a stronger signal than isolated buys.
How do IONS insider transactions affect options pricing?
Insider transaction data does not directly drive implied volatility, but Form 4 disclosures can move single-name IV if the size or timing is unusual (e.g. a large CEO buy ahead of an earnings window). Options markets price the marginal informational content; routine transactions under pre-scheduled plans are typically ignored. For event-driven options sizing, pair the insider transaction history with the upcoming earnings calendar.